Trials / Completed
CompletedNCT00401648
Effect of Brivaracetam in Photosensitive Epileptic Subjects
A Placebo-controlled, Single-blind, Multi-center Study to Explore the Photoparoxysmal Response in Photosensitive Epileptic Subjects After One Single Oral Dose of Brivaracetam in Capsules.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
to assess the effect of brivaracetam on the photoparoxysmal EEG response in photosensitive epileptic subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brivaracetam |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2003-06-01
- Completion
- 2003-06-01
- First posted
- 2006-11-20
- Last updated
- 2009-12-01
Locations
5 sites across 2 countries: France, Germany
Source: ClinicalTrials.gov record NCT00401648. Inclusion in this directory is not an endorsement.